The PAI-1 4G/5G and ACE I/D Polymorphisms and Risk of Recurrent Pregnancy Loss: A Case-Control Study

被引:21
|
作者
Kim, Jin Ju [1 ,2 ]
Choi, Young Min [2 ,3 ]
Lee, Sung Ki [4 ]
Yang, Kwang Moon [5 ,6 ]
Paik, Eun Chan [7 ]
Jeong, Hyeon Jeong [8 ]
Jun, Jong Kwan [3 ]
Han, Ae Ra [9 ]
Hong, Min A. [3 ]
机构
[1] Seoul Natl Univ Hosp, Healthcare Syst Gangnam Ctr, Dept Obstet & Gynecol, Seoul 110744, South Korea
[2] Seoul Natl Univ, Inst Reprod Med & Populat, Med Res Ctr, Coll Med, Seoul 110744, South Korea
[3] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul 110744, South Korea
[4] Konyang Univ, Dept Obstet & Gynecol, Coll Med, Taejon, South Korea
[5] Kwandong Univ, Cheil Gen Hosp, Dept Obstet & Gynecol, Coll Med, Seoul, South Korea
[6] Kwandong Univ, Coll Med, Womens Healthcare Ctr, Seoul, South Korea
[7] Bundangcheil Womens Hosp, Dept Obstet & Gynecol, Bundang, South Korea
[8] Seoul Rachel Fertil Ctr, Dept Obstet & Gynecol, Seoul, South Korea
[9] Kyungpook Natl Univ, Dept Obstet & Gynecol, Coll Med, Taegu, South Korea
关键词
Angiotensin converting enzyme; plasminogen activator inhibitor type 1; recurrent pregnancy loss; single-nucleotide polymorphisms; PLASMINOGEN-ACTIVATOR INHIBITOR-1; ANGIOTENSIN-CONVERTING ENZYME; GENETIC ASSOCIATION; MISCARRIAGE; WOMEN; EXPRESSION; GENOTYPE; SYSTEM;
D O I
10.1111/aji.12302
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
ProblemThrombophilia has been postulated to be a contributor to the pathophysiology of recurrent pregnancy loss (RPL). We investigated the role of the plasminogen activator inhibitor type 1 (PAI-1) 4G/5G and angiotensin converting enzyme (ACE) I/D polymorphisms in Korean patients with RPL. Method of studyGenotyping was performed using the TaqMan assay in 227 RPL patients and 304 controls. ResultsThe genotype distributions of both polymorphisms in the RPL group did not differ from those of controls. Because the frequency of being homozygous for ACE D/D and the PAI-I 4G/4G combination has been reported to be significantly higher in RPL patients, this was also analyzed. However, no significant difference was noted; 3.1% of RPL patients had both ACE D/D and PAI-I 4G/4G, as did 4.9% of controls (P=0.791). ConclusionThe current study suggests that both polymorphisms, either alone or in combination, are not major determinants of the development of RPL in Korean women.
引用
收藏
页码:571 / 576
页数:6
相关论文
共 50 条
  • [1] A meta-analysis of the association of the ACE I/D and PAI-1 4G/5G polymorphisms with recurrent pregnancy loss in Iranian women: Are the investigations adequate?
    Dastgheib, Seyed Alireza
    Karimi-Zarchi, Mojgan
    Bahrami, Reza
    Tabatabaei, Razieh Sadat
    Javaheri, Atiyeh
    Noorishadkam, Mahmood
    Mirjalili, Seyed Reza
    Neamatzadeh, Hossein
    TURKISH JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2021, 18 (02) : 139 - 150
  • [2] Association of Plasminogen Activator Inhibitor-1 4G/5G and Angiotensin-Converting Enzyme I/D Polymorphisms with Recurrent Pregnancy Loss in Sudanese Women: A Case-Control study
    Ahmed, Hanan K.
    Elgoraish, Amanda G.
    Abdalla, Selma Elmalieh
    Babker, Asaad MA.
    Alfeel, Ayman Hussien
    Abbas, Amin Omer Ibrahim
    Mohamedahmed, Khalid Abdelsamea
    Elzaki, Salaheldein G.
    INTERNATIONAL JOURNAL OF BIOMEDICINE, 2023, 13 (01) : 127 - 133
  • [3] Coexistence of ACE (I/D) and PAI-1(4G/5G) gene variants in recurrent miscarriage in Polish population
    Kurzawinska, Grazyna
    Barlik, Magdalena
    Drews, Krzysztof
    Rozycka, Agata
    Seremak-Mrozikiewicz, Agnieszka
    Oarowski, Marcin
    Klejewski, Andrzej
    Czerny, Boguslaw
    Wolski, Hubert
    GINEKOLOGIA POLSKA, 2016, 87 (04) : 271 - 276
  • [4] Association of PAI-1 4G/5G and ACE I/D Polymorphisms with Susceptibility to Pediatric Sepsis: Evidence from a Meta-Analysis
    Jarahzadeh, Mohammad Hosein
    Jafari, Mohammadali
    Seifi-Shalamzari, Neda
    Ferdosian, Farzad
    Bahrami, Reza
    Raee-Ezzabadi, Ali
    Nafei, Zahra
    Shajari, Ahmad
    Mirjalili, Seyed Reza
    Neamatzadeh, Hossein
    FETAL AND PEDIATRIC PATHOLOGY, 2022, 41 (02) : 242 - 258
  • [5] Association of PAI-1 4G/5G and-844G/A Gene Polymorphisms and Changes in PAI-1/Tissue Plasminogen Activator Levels in Myocardial Infarction: A Case-Control Study
    Abboud, Nesrine
    Ghazouani, Lakhdar
    Saidi, Sarra
    Ben-Hadj-Khalifa, Sonia
    Addad, Fawzi
    Almawi, Wassim Y.
    Mahjoub, Touhami
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2010, 14 (01) : 23 - 27
  • [6] Association between PAI-1 gene − 657 4G/5G polymorphism and preeclampsia in Egyptian women: a case-control study
    Omali Y. El-khawaga
    Afaf M. ElSaid
    Hwyda Ahmed
    Aliaa N. El-Daw
    Hend A. Shalaby
    Mohammed F. Al-azzawy
    Manar refaat
    BMC Pregnancy and Childbirth, 25 (1)
  • [7] The PAI-1 4G/5G polymorphism is not associated with an increased risk of adverse pregnancy outcome in asymptomatic nulliparous women
    Said, J. M.
    Tsui, R.
    Borg, A. J.
    Higgins, J. R.
    Moses, E. K.
    Walker, S. P.
    Monagle, P. T.
    Brennecke, S. P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (05) : 881 - 886
  • [8] The-675 4G/5G polymorphism in the PAI-1 gene may not contribute to the risk of PCOS
    Zhang, T. -T.
    Yuan, L.
    Yang, Y. -M.
    Ren, Y.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2014, 18 (16) : 2326 - 2331
  • [9] Plasma PAI-1 levels in obese children -: Effect of weight loss and influence of PAI-1 promoter 4G/5G genotype
    Estellés, A
    Dalmou, J
    Falcó, C
    Berbel, O
    Castelló, R
    España, F
    Aznar, J
    THROMBOSIS AND HAEMOSTASIS, 2001, 86 (02) : 647 - 652
  • [10] The Presence of PAI-1 4G/5G and ACE DD Genotypes Increases the Risk of Early-Stage AVF Thrombosis in Hemodialysis Patients
    Gungor, Yahya
    Kayatas, Mansur
    Yildiz, Gursel
    Ozdemir, Ozturk
    Candan, Ferhan
    RENAL FAILURE, 2011, 33 (02) : 169 - 175